Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001140361-25-023972·NATURES SUNSHINE PRODUCTS INC
Schedule 13D ownership disclosure
NATURES SUNSHINE PRODUCTS INC
Common Stock, no par value · CUSIP: 639027101
Event date: 2025-06-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Reported CIK 0001615258
Shares: 64,167 · Class: 0.35%
- Fosun Pharma USA Inc.Reported CIK 0002071437
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-023972
- Form type
- SCHEDULE 13D/A
- Filer
- NATURES SUNSHINE PRODUCTS INC
- CIK
- CIK 275053
- Filed
- Jun 27, 2025
- Reporting period
- Jun 25, 2025
- Description
- Schedule 13D beneficial ownership